Valneva SE (VALN) Total Debt (2020 - 2026)
Valneva SE (VALN) posted quarterly Total Debt of $207.5 million for Q1 2026, up 0.64% year-on-year from $206.2 million in Q1 2025, and up 1.77% on a QoQ basis from $203.9 million in Q4 2025.
Valneva SE (VALN) Total Debt (2020 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Total Debt for 7 consecutive years, with $207.5 million the latest figure, recorded in Q1 2026.
- Quarterly Total Debt rose 0.64% year-over-year to $207.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $207.5 million (up 0.64% YoY) and the FY2025 annual result came in at $203.9 million, down 4.38% from the prior year.
- Total Debt rose to $207.5 million in Q1 2026 per VALN's latest filing, from $203.9 million in the prior quarter.
- Over the last five years, Total Debt for VALN reached as high as $213.2 million in Q4 2024 and fell as low as $68.0 million in Q1 2022.
- A 5-year average of $164.3 million and a median of $191.6 million in 2025 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2024 — Total Debt soared 89.09% — and 2025, when it decreased 6.67%.
- Year by year, Total Debt stood at $112.4 million in 2022, then surged by 78.98% to $201.2 million in 2023, then rose by 5.95% to $213.2 million in 2024, then declined by 4.38% to $203.9 million in 2025, then gained by 1.77% to $207.5 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $207.5 million, $203.9 million, and $190.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 207.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 207.49 Mn |
| Dec 31, 2025 | 203.88 Mn |
| Sep 30, 2025 | 190.86 Mn |
| Jun 30, 2025 | 191.61 Mn |
| Mar 31, 2025 | 206.18 Mn |
| Dec 31, 2024 | 213.22 Mn |
| Sep 30, 2024 | 196.39 Mn |
| Jun 30, 2024 | 205.31 Mn |
| Mar 31, 2024 | 206.48 Mn |
| Dec 31, 2023 | 201.24 Mn |
| Sep 30, 2023 | 160.29 Mn |
| Jun 30, 2023 | 108.57 Mn |
| Mar 31, 2023 | 110.82 Mn |
| Dec 31, 2022 | 112.44 Mn |
| Sep 30, 2022 | 120.46 Mn |
| Jun 30, 2022 | 89.44 Mn |
| Mar 31, 2022 | 67.98 Mn |
| Dec 31, 2021 | 65.81 Mn |
| Dec 31, 2020 | 60.72 Mn |